KRYSTLE REED: Open Payments
NPI 1215216239 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 59 payments from 21 companies in 2025. Trend: 2023 $1,220 · 2024 $875 · 2025 $872
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $292 |
| PFIZER INC. | 4 | $80 |
| Exact Sciences Corporation | 3 | $53 |
| Lundbeck LLC | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Radius Health, Inc. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Lilly USA, LLC | 1 | $26 |
Products named: VRAYLAR, UBRELVY, REXULTI, QULIPTA, NURTEC ODT, JARDIANCE, The Cologuard Plus Collection Kit, Tymlos.
Industry payments across MO — which companies pay providers there.
